The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Can contemporary targeted therapies provide clinically meaningful changes in renal cell carcinoma venous tumor thrombi?
Scott Edward Delacroix
No relevant relationships to disclose
Brian F. Chapin
No relevant relationships to disclose
Nicholas Cost
No relevant relationships to disclose
Jose A. Karam
No relevant relationships to disclose
Stephen Hembree Culp
No relevant relationships to disclose
Edwin Jason Abel
No relevant relationships to disclose
Graciela Gonzalez
No relevant relationships to disclose
Vitaly Margulis
No relevant relationships to disclose
Christopher G. Wood
No relevant relationships to disclose